Stocks and Investing Stocks and Investing
Mon, March 29, 2021
Fri, March 26, 2021

Andrew Fein Maintained (ZNTL) at Strong Buy with Increased Target to $65 on, Mar 26th, 2021


Published on 2024-10-27 16:03:15 - WOPRAI, Andrew Fein
  Print publication without navigation


Andrew Fein of HC Wainwright & Co., Maintained "Zentalis Pharmaceuticals, Inc." (ZNTL) at Strong Buy with Increased Target from $43 to $65 on, Mar 26th, 2021.

Andrew has made no other calls on ZNTL in the last 4 months.



There are 2 other peers that have a rating on ZNTL. Out of the 2 peers that are also analyzing ZNTL, 0 agree with Andrew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Andrew


  • Robert Driscoll of "Wedbush" Initiated at Buy and Held Target at $65 on, Wednesday, January 20th, 2021
  • John Morrison of "Morgan Stanley" Maintained at Buy with Increased Target to $75 on, Wednesday, December 16th, 2020
Contributing Sources